Therefore, FoxO1 overexpression in pancreatic duct cells increases duct cell proliferation, which leads to pancreatic cyst formation, but at the same time it also inhibits β cell neogenesis from duct progenitors, resulting in the loss of β cells and hyperglycemia. This evidence concerns the gene FOXO1 and Pancreatic cysts.